¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ The 11th SFR Symposium : 2019-07-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ The 11th SFR Symposium : 2019-07-12
±³À°ÀÏÀÚ : 2019-07-12
±³À°Àå¼Ò : ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø º»°ü 5Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : The 11th SFR Symposium
ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
´ã´çÀÚ : Á¤ÀºÇý
¿¬¶ôó : 02-582-8212  
À̸ÞÀÏ : grace@kscvi.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 4 ½Ã°£ 12ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í -Àü¹®ÀÇ/°³¿øÀÇ/ÀϹÝÀÇ: 60,000 -ÀüÀÓÀÇ/Àü°øÀÇ: 30,000 -°£È£»ç/ÀÇ·á±â»ç/ÀÇ´ë»ý/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/ÀÓ»óº´¸®»ç/Àǹ«±â·Ï»ç: 20,000 -»ê¾÷ü/±âŸ: 120,000 * ÇöÀåµî·Ï¸¸ °¡´ÉÇÕ´Ï´Ù      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-12 ´ë°­´ç 13:30~13:41 How to Treat Type 1 & 2 ISR Lesions after Long Stent Implantation  Á¶À±°æ(°è¸íÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 13:41~13:52 What You Need to Know before rePCI for Type 3 & 4 ISR Lesions  ÀÌÀåÈÆ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 13:52~14:03 How to Treat for LM Bifurcation ISR Lesions after Simple Stenting  ÇÏ»óÁø(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 14:03~14:14 Do You Believe the Role of FFR for ISR Lesions?  ±èÇö±¹(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 14:14~14:25 Different Roles of Image Evaluation in ISR Lesions: IVUS vs. OCT  È«¿µÁØ(Àü³²ÀÇ´ë) 
Åä·Ð 07-12 ´ë°­´ç 14:25~14:30 Discussion  () 
±³À°½Ã°£ 07-12 ´ë°­´ç 14:30~14:41 Prevention & Management of TEVAR Complication/Failure  ÀÌÇÑö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 14:41~14:52 Prevention & Management of EVAR Complication/Failure  Ãµ¹Î±¸(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 14:52~15:03 Prevention & Management of Aortiliac Intervention Complication/Failure  ½Å»óÈÆ(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 15:03~15:14 Prevention & Management of FP Intervention Complication/Failure  À̽Âȯ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 15:14~15:25 Prevention & Management of BTK Intervention Complication/Failure  ÃÖÀÍÁØ(°¡Å縯ÀÇ´ë) 
Åä·Ð 07-12 ´ë°­´ç 15:25~15:30 Discussion  () 
È޽Ġ07-12  15:30~15:50 Coffee Break  () 
±³À°½Ã°£ 07-12 ´ë°­´ç 15:50~16:01 Does It Really Matter in Stent Failure?: Strut Coverage, Acute Malapposition, etc  ÀÌ»ó¿±(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 16:01~16:12 Role of Post-stent FFR in Prediction of Stent Failure  µµÁØÇü(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 16:12~16:23 Different Stent Design, Polymer, and Strut Thickness Make Different Acute and Chronic Outcomes  ¹Ú°æÀÏ(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 16:23~16:34 Future Direction of Newer Stents to Prevent Stent Failure  ±è¼öÁß(°æÈñÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 16:34~16:45 Medical Therapy to Prevent Stent Failure: Antiplatelet Therapy and Others  Á¤¿µÈÆ(°æ»óÀÇ´ë) 
Åä·Ð 07-12 ´ë°­´ç 16:45~16:50 Discussion  () 
±³À°½Ã°£ 07-12 ´ë°­´ç 16:50~17:02 Rotablation for Stent Underexpansion  ±èµ¿±â(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 17:02~17:14 We Need "Graft Stent"  ¹ÚÇÏ¿í(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 17:14~17:26 What Is the Best Strategy for the Treatment of Calcified Left Main Bifurcation Lesion?  ÀÌÁßÈñ(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 17:26~17:38 Endless Treatment of Severe Vascular Disease Patient  ÀÌöÇö(°è¸íÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 17:38~17:50 In-Stent CTO, Not as Easy as It Looks  Àü±¹Áø(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 07-12 ´ë°­´ç 17:50~18:02 Treatment Strategy of Totally IVUS and FFR Guided Recurrent LAD Stent Failure  È²º´Èñ(°¡Å縯ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ The 11th SFR Symposium : 2019-07-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ»çȸÁ¤½ÅÀÇÇÐȸ Çö´ë»çȸÀÇ ´Ü¸é°ú Á¤½Å°Ç°­ °³Çõ : 2019-07-12
´ÙÀ½±Û 2019 ´ëÇÑÀÇ·áÁ¤º¸ÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2019-07-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 34 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 34 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 30 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 25 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 29 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 41 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 23 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 22 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 21 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 21 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 19 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 22 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 24 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 26 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷